Scientific ReportsNeurosciencePeer-reviewed journal article
Intrinsically photosensitive retinal ganglion cell mediated pupil function is impaired in Parkinson’s disease
Daniel S. JoyceiD, Beatrix FeigliD, Graham KerriD, Luisa RoederiD, Andrew J. ZeleiD
Abstract
Parkinsons disease is characterised by non-motor symptoms including sleep and circadian disruption, but the underlying aetiology is not well understood. Melanopsin-expressing intrinsically photosensitive Retinal Ganglion Cells (ipRGC) transmit light signals from the eye to brain areas controlling circadian rhythms and the pupil light reflex. Here we evaluate the hypothesis that these non-motor symptoms in people with Parkinsons disease may be linked to ipRGC dysfunction. Using chromatic pupillometry, we measured intrinsic (melanopsin-mediated) ipRGC and extrinsic (rod/cone photoreceptor-mediated) inputs to the pupil control pathway in a group of optimally medicated participants with a diagnosis of Parkinsons disease (PD, n = 17) compared to controls (n = 12). Autonomic tone was evaluated by measuring pupillary unrest in darkness. The PD participants underwent additional clinical assessments using the Unified Parkinsons disease Rating Scale (UPDRS) and the Hoehn and Yahr scale (H&Y).\n\nCompared to controls, the PD group demonstrated an attenuated pupil constriction amplitude in response to long wavelength pulsed stimulation, and reduced post-illumination pupil response (PIPR) amplitude in response to both short wavelength pulsed and sinusoidal stimulation. In the PD group, PIPR amplitude did not correlate with measures of sleep quality, retinal nerve fibre layer thickness, UPDRS or H&Y score, or medication dosage. Both groups exhibited similar pupillary unrest in darkness.\n\nWe show that melanopsin and the rod/cone-photoreceptor contributions to the pupil control pathway are impaired in people with early-stage Parkinsons disease. Given that the deficits are independent of clinical assessment severity and are observed despite optimal medication, the melanopsin-mediated PIPR may be a biomarker for the detection of Parkinsons disease and its continued monitoring in both medicated and unmedicated individuals.
- Citations
- 89
- FWCI
- 6.18
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dopamine and eye movement control in Parkinson’s disease: deficits in corollary discharge signals?
Henry Railo, Henri Olkoniemi, … Valtteri Kaasinen·PeerJPeer-reviewed·Dec 7, 2018
- Preservation of eye movements in Parkinson's disease is stimulus and task specific
Jolande Fooken, Pooja Patel, … Miriam Spering·Journal of NeurosciencePeer-reviewed·Nov 30, 2021
- REM sleep predicts reductions in pathophysiological daytime basal ganglia-cortical circuit activity in Parkinson's disease
Jinxiao Zhang, Clay N Smyth, … Simon J Little·bioRxiv·May 7, 2025
- Dynamics of visual contextual interactions is altered in Parkinson's disease
M. Isabel Vanegas, Annabelle Blangero, … Simon P. Kelly·npj Parkinson s DiseasePeer-reviewed·Jul 4, 2019
- Functional and morphological alterations of the light perception circuits in postmortem retina from donors at different stages of Alzheimer's disease
Nicolae Sanda, Dan Miléa, … Ludovic S. Mure·bioRxiv·Feb 18, 2025
- Medication-Invariant Resting Aperiodic and Periodic Neural Activity in Parkinson's Disease
Daniel J. McKeown, Manon Jones, … Douglas J. Angus·PsychophysiologyPeer-reviewed·Nov 8, 2023